Influence of gestational age on fibrinolysis from birth to postnatal day 10

Journal of Pediatrics

Volumn 158, Issue 3, 2011, Pages

  Sentilhes, Loïc ^a,b   Leroux, Philippe ^a   Radi, Sophie ^b   Ricbourg Schneider, Aude ^b   Laudenbach, Vincent ^a,b   Marpeau, Loïc ^b   Bénichou, Jacques ^b   Vasse, Marc ^b   Marret, Stéphane ^a,b  

^a Institute for Biomedical Research   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BIRTH; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; GESTATIONAL AGE; HUMAN; MOTHER; NEWBORN; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 79951563796     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.08.033     Document Type: Article

References (23)

1. J.J. Volpe Neurology of the Newborn 5th ed. 2008 Elsevier Philadelphia
2. J.J. Volpe Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances Lancet Neurol 8 2009 110 124
3. P. Ballabh, H. Xu, F. Hu, A. Braun, K. Smith, and A. Rivera Angiogenic inhibition reduces germinal matrix hemorrhage Nat Med 13 2007 477 485 (Pubitemid 46559829)
4. P. Reverdiau-Moalic, B. Delahousse, G. Body, P. Bardos, J. Leroy, and Y. Gruel Evolution of blood coagulation activators and inhibitors in the healthy human fetus Blood 88 1996 900 906 (Pubitemid 26333312)
5. M. Andrew The relevance of developmental hemostasis to hemorrhagic disorders of newborns Semin Perinatol 21 1997 70 85 (Pubitemid 27247329)
6. H.A. Bremer, E.J. Brommer, and H.C. Wallenburg Effects of labor and delivery on fibrinolysis Eur J Obstet Gynecol Reprod Biol 55 1994 163 168 (Pubitemid 24212330)
7. J.P. Chen, and V. Lorch Intraventricular haemorrhage in preterm infants: evidence of suppressed fibrinolysis Blood Coag Fibrinol 7 1996 289 294 (Pubitemid 26182926)
8. R.V. McVeen, V. Lorch, R.C. Carroll, L. Goldberg, M. Keszler, and S. Podlasek Changes in fibrinolytic factors in newborns during extracorporeal membrane oxygenation (ECMO) Am J Hematol 38 1991 254 255
9. P. Reverdiau-Moalic, Y. Gruel, B. Delahousse, A. Rupin, M.C. Huart, and G. Body Comparative study of the fibrinolytic system in human fetuses and in pregnant women Thromb Res 61 1991 489 499
10. I. Lecander, and B. Astedt Specific plasminogen activator inhibitor of placental type PAI2 occurring in amniotic fluid and cord blood J Lab Clin Med 110 1987 602 605 (Pubitemid 18033251)
11. B. Brenner Haemostatic changes in pregnancy Thromb Res 114 2004 409 414 (Pubitemid 39422573)
12. P. Sie, C. Caron, J. Azam, J. Goudemand, H. Grandjean, and B. Boneu Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII: C and plasminogen activator inhibitors 1 and 2 during normal pregnancy Br J Haematol 121 2003 897 903 (Pubitemid 36760309)
13. A. Estelles, J. Gilabert, F. Espana, J. Aznar, and M. Galbis Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia Am J Obstet Gynecol 165 1991 138 142
14. P. Chabloz, G. Reber, F. Boehlen, P. Hohlfeld, and P. de Moerloose TAFI antigen and D-dimer levels during normal pregnancy and at delivery Br J Haematol 115 2001 150 152 (Pubitemid 32995109)
15. T. Watanabe, H. Minakami, Y. Sakata, S. Matsubara, I. Sato, and M. Suzuki Changes in activity of plasma thrombin activatable fibrinolysis inhibitor in pregnancy Gynecol Obstet Invest 58 2004 19 21 (Pubitemid 39140402)
16. M. Franzoi, P. Simioni, S. Luni, P. Zerbinati, A. Girolami, and V. Zanardo Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate Thromb Res 105 2002 15 18
17. A. Mautone, P. Giordano, O. Montagna, M. Quercia, M. Altomare, and D. De Mattia Coagulation and fibrinolytic system in the ill preterm newborn Acta Paediatr 86 1997 1100 1104 (Pubitemid 27443719)
18. H. Bassan, C. Limperopoulos, K. Visconti, D.L. Mayer, H.A. Feldman, and L. Avery Neurodevelopmental outcome in survivors of periventricular hemorrhagic infarction Pediatrics 120 2007 785 792 (Pubitemid 47549567)
19. E. Roze, J.M. Kerstjens, C.G. Maathuis, H.J. ter Horst, and A.F. Bos Risk factors for adverse outcome in preterm infants with periventricular hemorrhagic infarction Pediatrics 122 2008 e46 e52
20. J.J. Volpe Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis Semin Pediatr Neurol 5 1998 135 151 (Pubitemid 28432520)
21. M.R. Golomb Sinovenous thrombosis in neonates Semin Cerebrovasc Dis Stroke 1 2001 216 224
22. M.R. Golomb The contribution of prothrombotic disorders to peri- and neonatal ischemic stroke Semin Thromb Hemost 29 2003 415 424 (Pubitemid 37059768)
23. M.R. Golomb, M. Heiny, and B.P. Garg Two cousins with neonatal stroke, PAI-1 4G variant and MTHFR A1298C mutation J Child Neurol 22 2007 753 755 (Pubitemid 47034384)